Heron Therapeutics Inc
HRTX
Market Cap$286.82M
Close$
$3.67
83.5% upside
Current Fair Value
83.5% upsideUndervalued by 83.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $286.82 Million |
|---|---|
| Enterprise Value | $444.81 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.09 |
| Beta | 1.33 |
| Outstanding Shares | 153,490,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -37.07 |
|---|---|
| PEG | 20.21 |
| Price to Sales | 2.0 |
| Price to Book Ratio | -2.0 |
| Enterprise Value to Revenue | 2.82 |
| Enterprise Value to EBIT | -138.83 |
| Enterprise Value to Net Income | -58 |
| Total Debt to Enterprise | 0.4 |
| Debt to Equity | -6.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Heron Therapeutics Inc
CEO: Barry Quart